2- n- (1,2-benzisothiasolyl-3 (2h) ona- 1,1-ethyl dioxide) 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carboxylate

摘要

Invention Patent of "" 5-ETOXICARBONYL-2,4,6-TRIMETHYL-1,4, -DIIPROPYRIDINE-3-CAR BOXYLATE 2- [N- (1,2-BENZISO-THIAZOLYL-3 (2H) ONA-1,1- DIOXIDE] ETHYL The invention essentially reveals the application of this product as a therapeutic agent to treat patients who suffer from atherosclerosis and / or restenosis and who are in serious risk of occlusion of the vessels affected by the diseases. be administered by mouth or parenterally, associated or not with other drugs, to patients suffering from atherosclerosis to reduce atheromatous injury and prevent restenosis of blood vessels.